IOVA - Iovance Biotherapeutics GAAP EPS of -$0.47 beats by $0.38 revenue of $0.24M August, 08 2023 04:17 PM Iovance Biotherapeutics Inc. 2023-08-08 16:17:18 ET Iovance Biotherapeutics press release ( NASDAQ: IOVA ): Q2 GAAP EPS of -$0.47 beats by $0.38 . Revenue of $0.24M. For further details see: Iovance Biotherapeutics GAAP EPS of -$0.47 beats by $0.38, revenue of $0.24M